Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pyloric stenosis
ADR ID BADD_A03678
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.04      Gastrointestinal tract disorders congenital
03.04.05      Gastric disorders congenital
03.04.05.001      Pyloric stenosis
07      Gastrointestinal disorders
07.13      Gastrointestinal stenosis and obstruction
07.13.04      Gastric and pyloric stenosis and obstruction
07.13.04.001      Pyloric stenosis
Description Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants. [MeSH]
MedDRA Code 10037621
MeSH ID D011707
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Congenital hypertrophic pyloric stenosis | Congenital pyloric stenosis | Obstruction pyloric | Pyloric stenosis | Pyloric stenosis congenital | Pyloric stenosis NOS | Pylorus hypertrophic congenital | Stenosis pyloric | Stenosis pyloric hypertrophic congenital | Pyloric Stenosis | Stenosis, Pyloric
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00203Azithromycin--
BADD_D00204Azithromycin dihydrate--
BADD_D00205Azithromycin monohydrate--
BADD_D00475Citalopram0.000087%
BADD_D00488Clobazam0.000157%
BADD_D00802Ertapenem--
BADD_D00803Ertapenem sodium--
BADD_D00804Erythromycin--
BADD_D00932Fluoxetine0.000047%
BADD_D00981Gabapentin0.000020%
BADD_D01265Levetiracetam0.000099%
BADD_D01476Mirtazapine0.000095%
BADD_D01624Orlistat0.006762%
BADD_D01627Oseltamivir0.000226%
BADD_D01653Paclitaxel0.000139%
BADD_D01679Paroxetine0.000293%
BADD_D01803Porfimer sodium0.000139%
BADD_D01888Quetiapine0.000066%
BADD_D02010Sertraline0.000032%
BADD_D02346Venlafaxine0.000117%
BADD_D02464Fingolimod0.001158%
The 1th Page    1    Total 1 Pages